NCT04668339Phase 2Terminated

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

Study sponsor: Arcturus Therapeutics, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-03-01Actual
Enrollment · participants581Actual
Source updated2025-05-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview